269
Views
2
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Predictive Factors of Menstrual Recovery After Laparoscopic Sleeve Gastrectomy in Polycystic Ovary Syndrome Women with Obesity

, , , , , , , , , ORCID Icon & ORCID Icon show all
Pages 1755-1766 | Received 09 Mar 2023, Accepted 01 Jun 2023, Published online: 13 Jun 2023

References

  • Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284. doi:10.1038/nrendo.2018.24
  • Stener-Victorin E, Deng Q. Epigenetic inheritance of polycystic ovary syndrome - challenges and opportunities for treatment. Nat Rev Endocrinol. 2021;17(9):521–533. doi:10.1038/s41574-021-00517-x
  • Barber TM, Franks S. Obesity and polycystic ovary syndrome. Clin Endocrino. 2021;95(4):531–541. doi:10.1111/cen.14421
  • Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. doi:10.1016/j.metabol.2018.11.002
  • Christ JP, Falcone T. Bariatric surgery improves hyperandrogenism, menstrual irregularities, and metabolic dysfunction among women with polycystic ovary syndrome (PCOS). Obes Surg. 2018;28(8):2171–2177. doi:10.1007/s11695-018-3155-6
  • Tian Z, Zhang YC, Wang Y, Chang XH, Zhu HL, Zhao Y. Effects of bariatric surgery on patients with obesity and polycystic ovary syndrome: a meta-analysis. Surg Obes Relat Dis. 2021;17(8):1399–1408. doi:10.1016/j.soard.2021.04.009
  • Mihm M, Gangooly S, Muttukrishna S. The normal menstrual cycle in women. Anim Reprod Sci. 2011;124(3–4):229–236. doi:10.1016/j.anireprosci.2010.08.030
  • Messinis IE, Messini CI, Dafopoulos K. Novel aspects of the endocrinology of the menstrual cycle. Reprod Biomed Online. 2014;28(6):714–722. doi:10.1016/j.rbmo.2014.02.003
  • Rostami Dovom M, Ramezani Tehrani F, Djalalinia S, Cheraghi L, Behboudi Gandavani S, Azizi F. Menstrual cycle irregularity and metabolic disorders: a population-based prospective study. PLoS One. 2016;11(12):e0168402. doi:10.1371/journal.pone.0168402
  • Wang YX, Wang S, Mitsunami M, et al. Pre-pregnancy menstrual cycle regularity and length and the risk of gestational diabetes mellitus: prospective cohort study. Diabetologia. 2021;64(11):2415–2424. doi:10.1007/s00125-021-05531-2
  • Thong EP, Codner E, Laven JSE, Teede H. Diabetes: a metabolic and reproductive disorder in women. Lancet Diabetes Endocrinol. 2020;8(2):134–149. doi:10.1016/S2213-8587(19)30345-6
  • Jamal M, Gunay Y, Capper A, Eid A, Heitshusen D, Samuel I. Roux-en-Y gastric bypass ameliorates polycystic ovary syndrome and dramatically improves conception rates: a 9-year analysis. Surg Obes Relat Dis. 2012;8(4):440–444. doi:10.1016/j.soard.2011.09.022
  • Turkmen S, Ahangari A, Bäckstrom T. Roux-en-Y gastric bypass surgery in patients with polycystic ovary syndrome and metabolic syndrome. Obes Surg. 2016;26(1):111–118. doi:10.1007/s11695-015-1729-0
  • Eid GM, Cottam DR, Velcu LM, et al. Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2005;1(2):77–80. doi:10.1016/j.soard.2005.02.008
  • Hu L, Ma L, Xia X, et al. Efficacy of bariatric surgery in the treatment of women with obesity and polycystic ovary syndrome. J Clin Endocrinol Metab. 2022;107(8):e3217–e3229. doi:10.1210/clinem/dgac294
  • Lv B, Xing C, He B. Effects of bariatric surgery on the menstruation- and reproductive-related hormones of women with obesity without polycystic ovary syndrome: a systematic review and meta-analysis. Surg Obes Relat Dis. 2022;18(1):148–160. doi:10.1016/j.soard.2021.09.008
  • Różańska-Walędziak A, Bartnik P, Kacperczyk-Bartnik J, Czajkowski K, Walędziak M. The impact of bariatric surgery on menstrual abnormalities-a cross-sectional study. Obes Surg. 2020;30(11):4505–4509. doi:10.1007/s11695-020-04840-6
  • Wilson R, Aminian A, Tahrani AA. Metabolic surgery: a clinical update. Diabetes Obes Metab. 2021;23:63–83. doi:10.1111/dom.14235
  • Du Y, Zhang J, Chen G, Sun Z. Formulation and interpretation of the Chinese guidelines for surgical treatment of obesity and type 2 diabetes mellitus. Biosci Trends. 2021;15(5):299–304. doi:10.5582/bst.2021.01287
  • The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–47. doi:10.1093/humrep/deh098
  • Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110(3):364–379. doi:10.1016/j.fertnstert.2018.05.004
  • Misra M, Prabhakaran R, Miller KK, et al. Weight gain and restoration of menses as predictors of bone mineral density change in adolescent girls with anorexia nervosa-1. J Clin Endocrinol Metab. 2008;93(4):1231–1237. doi:10.1210/jc.2007-1434
  • Rosenfield RL. Hirsutism. N Engl J Med. 2011;353:2578–2588. doi:10.1056/NEJMcp033496
  • Carandina S, Soprani A, Zulian V, Cady J. Long-term results of one anastomosis gastric bypass: a single center experience with a minimum follow-up of 10 years. Obes Surg. 2021;31(8):3468–3475. doi:10.1007/s11695-021-05455-1
  • O’Brien PE, Hindle A, Brennan L, et al. Long-Term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding. Obes Surg. 2019;29(1):3–14. doi:10.1007/s11695-018-3525-0
  • Yang W, Liu J, Shan Z, et al. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomized trial. Lancet Diabetes. 2014;2:46–55. doi:10.1016/S2213-8587(13)70021-4
  • Lin SY, Li WC, Yang TA, et al. Optimal threshold of homeostasis model assessment of insulin resistance to identify metabolic syndrome in a Chinese population aged 45 years or younger. Front Endocrinol (Lausanne). 2022;12:746747. doi:10.3389/fendo.2021.746747
  • Keelan JA, Mattes E, Tan H, et al. Androgen concentrations in umbilical cord blood and their association with maternal, fetal and obstetric factors. PLoS One. 2012;7(8):e42827. doi:10.1371/journal.pone.0042827
  • Dhaliwal R, Shepherd JA, El Ghormli L, et al. Changes in visceral and subcutaneous fat in youth with type 2 diabetes in the TODAY study. Diabetes Care. 2019;42(8):1549–1559. doi:10.2337/dc18-1935
  • Dabravolski SA, Nikiforov NG, Eid AH, et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci. 2021;22(8):3923. doi:10.3390/ijms22083923
  • Balen AH, Morley LC, Misso M, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687–708. doi:10.1093/humupd/dmw025
  • Pazderska A, Kyaw Tun T, Phelan N, et al. In women with PCOS, waist circumference is a better surrogate of glucose and lipid metabolism than disease status per se. Clin Endocrinol. 2018;88(4):565–574. doi:10.1111/cen.13542
  • Cai M, Gao J, Du L, et al. The changes in body composition in obese patients with polycystic ovary syndrome after laparoscopic sleeve gastrectomy: a 12-month follow-up. Obes Surg. 2021;31(9):4055–4063. doi:10.1007/s11695-021-05496-6
  • Mu L, Pan J, Yang L, et al. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome. Reprod Biol Endocrinol. 2018;16(1):104. doi:10.1186/s12958-018-0419-x
  • Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942–960. doi:10.1093/humupd/dmaa029
  • Zhuang C, Luo X, Wang W, Sun R, Qi M, Yu J. Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: a systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:822079. doi:10.3389/fcvm.2022.822079
  • Liu XH, Qi LW, Alolga RN, Liu Q. Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: the need to harness its full potential. Int J Biol Sci. 2022;18(1):292–300. doi:10.7150/ijbs.66834
  • Dilimulati D, Du L, Huang X, et al. Serum fibrinogen-like protein 1 levels in obese patients before and after laparoscopic sleeve gastrectomy: a six-month longitudinal study. Diabetes Metab Syndr Obes. 2022;15:2511–2520. doi:10.2147/DMSO.S374011
  • Zhang Y, Dilimulati D, Chen D, et al. Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case-control study. J Endocrinol Invest. 2022;45(11):2123–2130. doi:10.1007/s40618-022-01844-0
  • Richards JS. The ovarian cycle. Vitam Horm. 2018;107:1–25. doi:10.1016/bs.vh.2018.01.009
  • Li YJ, Han Y, He B. Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis. Surg Obes Relat Dis. 2019;15(6):942–950. doi:10.1016/j.soard.2019.03.032
  • Martinou E, Stefanova I, Iosif E, Angelidi AM. Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery. Int J Mol Sci. 2022;23(6):3339. doi:10.3390/ijms23063339
  • Moffett RC, Naughton V. Emerging role of GIP and related gut hormones in fertility and PCOS. Peptides. 2020;125:170233. doi:10.1016/j.peptides.2019.170233
  • Yue W, Huang X, Zhang W, et al. Metabolic Surgery on Patients with Polycystic Ovary Syndrome: a Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne). 2022;13:848947. doi:10.3389/fendo.2022.848947
  • Goodman NF, Cobin RH, Futterweit W, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome--Part 1. Endocr Pract. 2015;21(11):1291–1300. doi:10.4158/EP15748.DSC
  • Zhang D, Gao J, Liu X, Qin H, Wu X. Effect of three androgen indexes (FAI, FT, and TT) on clinical, biochemical, and fertility outcomes in women with polycystic ovary syndrome. Reprod Sci. 2021;28(3):775–784. doi:10.1007/s43032-020-00316-1
  • Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520. doi:10.1210/er.2015-1104
  • Yang Z, Zhou W, Zhou C, et al. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2021;206:105806. doi:10.1016/j.jsbmb.2020.105806